Apoptosis inhibitors for heart disease.
Webster
Keith A
KA
Department of Molecular and Cellular Pharmacology, University of Miami Medical Center, 1600 NW 10th Avenue, RMSB 6038, Miami, Fla 33136, USA. kwebster@chroma.med.miami.edu
Bishopric
Nanette H
NH
D000818:Animals; D017209:Apoptosis; D002303:Cardiac Output, Low / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D006332:Cardiomegaly / Q000209:etiology; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000473:pathology; D061945:Caspase Inhibitors; D015853:Cysteine Proteinase Inhibitors / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D043802:GTP-Binding Protein alpha Subunits, Gq-G11 / Q000235:genetics / Q000502:physiology; D006331:Heart Diseases / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D051379:Mice; D008822:Mice, Transgenic; D008928:Mitochondria / Q000502:physiology; D009842:Oligopeptides / Q000627:therapeutic use; D011247:Pregnancy
D061945:Caspase Inhibitors; D015853:Cysteine Proteinase Inhibitors; D007211:Indoles; C118798:N-((1,3-dimethylindole-2-carbonyl)-valinyl)-3-amino-4-oxo-5-fluoropentanoic acid; D009842:Oligopeptides; D043802:GTP-Binding Protein alpha Subunits, Gq-G11